CIBC Raises WELL Health Technologies (TSE:WELL) Price Target to C$7.00

WELL Health Technologies (TSE:WELL - Free Report) had its price objective lifted by CIBC from C$5.25 to C$7.00 in a report released on Friday morning,BayStreet.CA reports.

Several other equities research analysts have also commented on WELL. Haywood Securities boosted their price objective on shares of WELL Health Technologies from C$8.00 to C$10.00 in a research report on Friday. Ventum Financial dropped their target price on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a "buy" rating for the company in a research report on Tuesday, October 29th.

WELL Health Technologies Stock Performance

WELL stock traded down C$0.09 on Friday, hitting C$6.79. The company's stock had a trading volume of 1,806,803 shares, compared to its average volume of 884,265. The company has a current ratio of 1.25, a quick ratio of 1.02 and a debt-to-equity ratio of 41.57. The stock has a market cap of C$1.69 billion, a price-to-earnings ratio of 11.91, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. The firm has a 50 day moving average of C$5.14 and a two-hundred day moving average of C$4.69. WELL Health Technologies has a 1 year low of C$3.41 and a 1 year high of C$7.02.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.